INTERNATIONAL PATENT: ELEVA GMBH FILES APPLICATION FOR "SUBCUTANEOUS ADMINISTRATION OF SIALYLATED HUMAN FACTOR H PROTEIN"

GENEVA, May 4 -- ELEVA GMBH (Hans-Bunte-Str. 1979108 Freiburg im Breisgau) filed a patent application (PCT/EP2025/080521) for "SUBCUTANEOUS ADMINISTRATION OF SIALYLATED HUMAN FACTOR H PROTEIN" on Oct 22, 2025. With publication no. WO/2026/087607, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DABROWSKA-SCHLEPP, Paulina (c/o eleva GmbHHans-Bunte-Str. 1979108 Freiburg im Breisgau), SIEVERT, Christian (c/o eleva GmbHHans-Bunte-Str. 1979108 Freiburg im Breisgau), KRIEGHOFF, Nicola (c/o eleva GmbHHans-Bunte-Str. 1979108 Freib...